Back

Drug-eluting balloons and drug-eluting stents in the treatment of small vessel coronary artery disease: a systematic review and metanalysis of long-term clinical and angiographic outcomes.

29 August 2022 (10:15 - 10:40)
Organised by:
Congress Presentation Part of: Predicting percutaneous coronary intervention outcomes Percutaneous Coronary Intervention (PCI) ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Greg Murphy

St. James's Hospital, Dublin (Ireland)

2 More presentations in this session

Presentation thumbnail
Consenting practices in interventional cardiology: an analysis from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Doctor C. Rajkumar (London, GB)
Abstract Slides
Presentation thumbnail
Early vascular responses to abluminal biodegradable polymer-coated versus circumferential durable polymer-coated newer-generation drug-eluting stents in humans: a pathologic study
Doctor Y. Kawagoe (Kawasaki, JP)
Abstract Slides

Access the full session

Session thumbnail
Predicting percutaneous coronary intervention outcomes

The Event

Event poster

ESC Congress 2022

29 August 2022 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Long-term outcomes of drug coated balloons versus drug eluting stents in patients with small vessel coronary artery disease
1 September 2025
thumbnail
Congress Presentation
Thirty-days versus standard duration of dual antiplatelet treatment after percutaneous coronary interventions: a systematic review and meta-analysis
27 August 2022
thumbnail
Congress Presentation
Systematic review and meta-analysis on the diagnostic accuracy for the detection of relevant coronary artery stenosis of vasodilator myocardial perfusion CMR and dobutamine stress echocardiography
31 August 2019
thumbnail
Congress Presentation
Incidence and outcomes of bailout stenting following use of drug coated balloon
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources